Continuing Education
The CSTE Annual Conference is a gathering of public health professionals and practitioners focused on epidemiology and informatics. Each year the conference content is determined by the abstracts submitted.
The educational purpose of the CSTE Annual Conference is to offer professionals and practitioners the opportunity to enhance their knowledge, improve their surveillance and epidemiology skills, and exchange information on best practices and strategies in applied epidemiology.
Learning Objectives
- Identify best practices in applied epidemiology.
- Describe best practices for surveillance and epidemiology.
- Discuss public health practice skills presented in workshops.
- Identify strategies or tools to improve public health practice.
- Articulate the importance of interprofessional collaboration for applied epidemiology.
Types of Continuing Education
CSTE has partnered with CDC to provide continuing education for conference attendees. Eligible sessions include the NASPHV business meeting, Sunday workshops, and plenaries. CSTE anticipates offering up to 20 hours of continuing education for:
- Doctors
- Nurses
- Health Educators
- Veterinarians
- Certified in Public Health
- General Practitioners
- Pharmacists
- Lawyers*
For questions about Continuing Education, contact [email protected].
INSTRUCTIONS FOR CLAIMING CONTINUING EDUCATION
Doctors, Nurses, Veterinarians, Pharmacists, Health Educators, Certified in Public Health, CEUs
In order to receive continuing education (CE) for CM4736 or SP4847, 2024 CSTE Annual Conference, please visit TCEO and follow these 9 Simple Steps before July 15, 2024.
The event code to claim CE for doctors, nurses, veterinarians, health educators, those Certified in Public Health or to obtain a certificate of attendance, use CM4736.
The event code to claim CE for pharmacists is SP4847.
The course access code is CSTEAC2024
Register for the 2024 CSTE Annual Conference. Attend including NASPHV business meeting, Sunday workshops, and plenaries. Complete the evaluation with the above event and course access codes at www.cdc.gov/GetCE
Certified in Infection Control
The 2024 CSTE Annual Conference is approved by Certification Board of Infection Control and Epidemiology as a multi-day conference for IPUs. To claim your IPUs, claim CEUs through www.cdc.gov/GetCE using the event code CM4736 and course access code CSTEAC2024. This will generate a certificate of attendance that can be submitted to CBIC.
Public Health Lawyers
*For all Lawyers claiming CLEs, contact Sunbal Virk at [email protected] to request session presentations and documents for the following eligible sessions or with questions related to CLE for Lawyers:
- Pre-conference workshop: Elevating Public Health Through Laws & Policies, Sunday, June 9th 8:00am-5:00 PM
FEES: Paid conference registration is required to receive CE. No additional fees are necessary to be eligible for CE for doctors, nurses, veterinarians, pharmacists health educators, or those Certified in Public Health.
Additional fees may apply for lawyers claiming CLE. Relevant CLE sessions are pending GA State Bar approval and if approved, will be offered at a discounted rate to be paid by attendee. All fees to be paid by the lawyer.
Disclosure
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners and presenters wish to disclose they have no financial relationship(s) with ineligible companies with the exception of with the exception of:
- Isaac Ghiani, MSc, MBBS and he wishes to disclose he was employed as a medical director in the Medical Countermeasures team at Emergent BioSolutions from February to October 2023.
- Genny Grilli, MPH and she wishes to disclose that her spouse receives compensation for employment from Abbott but there is no overlap in the content areas of their work.
Planning committee reviewed content to ensure there is no bias. All of the relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Mr. Richard Chapman’s discussion of OneHealth. He will be discussing as part of the research and management of wildlife rabies, the USDA, APHIS, National Rabies Management Program experimentally distribute millions of doses of the ONRAB oral rabies vaccine each year manufactured by Artemis Technologies, Inc., an indirect, wholly owned subsidiary of Ceva Sante Animale, S.A., Guelph, Ontario, Canada. We also use the rabies vaccine IMRAB®3 off label to vaccinate rabies vector species.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
For additional questions regarding continuing education, please contact Jessica Arrazola at ([email protected]).
